Matches in SemOpenAlex for { <https://semopenalex.org/work/W4324144311> ?p ?o ?g. }
- W4324144311 endingPage "1747" @default.
- W4324144311 startingPage "1747" @default.
- W4324144311 abstract "Background: Bridging therapy (BT) with systemic therapy (ST), radiation therapy (RT), or combined-modality therapy (CMT) is increasingly being utilized prior to chimeric antigen receptor (CAR) T-cell therapy for large B-cell lymphoma (LBCL). We report the long-term outcomes of the patients who received commercial CAR T-cell therapy with or without BT. Methods: The patients with LBCL who underwent infusion of a commercial CD19 CAR T product were eligible. The radiation was stratified as comprehensive or focal. The efficacy outcomes and toxicity were analyzed. Results: In total, 156 patients were included and, of them, 52.5% of the patients received BT. The median progression-free survival (PFS) was 0.65 years in the BT cohort compared to 1.45 years in the non-BT cohort. The median overall survival (OS) was 3.16 years in the BT cohort and was not reached in the non-BT cohort. The patients who received comprehensive radiation (versus focal) had significantly improved PFS and OS, achieving a 1-year PFS of 100% vs. 9.1% and 1-year OS of 100% vs. 45.5%. There was no difference in the severe toxicity between any of the nonbridging or BT cohorts. Conclusions: BT did not appear to compromise outcomes with respect to response rates, disease control, survival, and toxicity. The patients with limited disease treated with RT had favorable outcomes." @default.
- W4324144311 created "2023-03-15" @default.
- W4324144311 creator A5001438849 @default.
- W4324144311 creator A5010201318 @default.
- W4324144311 creator A5012169173 @default.
- W4324144311 creator A5013241767 @default.
- W4324144311 creator A5025327083 @default.
- W4324144311 creator A5027733252 @default.
- W4324144311 creator A5030788778 @default.
- W4324144311 creator A5037908394 @default.
- W4324144311 creator A5044247994 @default.
- W4324144311 creator A5044489687 @default.
- W4324144311 creator A5054770306 @default.
- W4324144311 creator A5055575949 @default.
- W4324144311 creator A5063781871 @default.
- W4324144311 creator A5068203031 @default.
- W4324144311 creator A5082326885 @default.
- W4324144311 creator A5089084282 @default.
- W4324144311 date "2023-03-14" @default.
- W4324144311 modified "2023-09-30" @default.
- W4324144311 title "Long-Term Follow-Up of Bridging Therapies Prior to CAR T-Cell Therapy for Relapsed/Refractory Large B Cell Lymphoma" @default.
- W4324144311 cites W1997353354 @default.
- W4324144311 cites W2030736011 @default.
- W4324144311 cites W2119147717 @default.
- W4324144311 cites W2150587745 @default.
- W4324144311 cites W2598700764 @default.
- W4324144311 cites W2744261860 @default.
- W4324144311 cites W2754562068 @default.
- W4324144311 cites W2771352624 @default.
- W4324144311 cites W2773804840 @default.
- W4324144311 cites W2790373585 @default.
- W4324144311 cites W2889673537 @default.
- W4324144311 cites W2903062212 @default.
- W4324144311 cites W2905654445 @default.
- W4324144311 cites W2944998775 @default.
- W4324144311 cites W2950480110 @default.
- W4324144311 cites W2954869918 @default.
- W4324144311 cites W3024978145 @default.
- W4324144311 cites W3026897105 @default.
- W4324144311 cites W3037322433 @default.
- W4324144311 cites W3179559390 @default.
- W4324144311 cites W3208432177 @default.
- W4324144311 cites W4200445707 @default.
- W4324144311 cites W4205736005 @default.
- W4324144311 cites W4283023614 @default.
- W4324144311 cites W4293241248 @default.
- W4324144311 cites W4307145842 @default.
- W4324144311 doi "https://doi.org/10.3390/cancers15061747" @default.
- W4324144311 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36980632" @default.
- W4324144311 hasPublicationYear "2023" @default.
- W4324144311 type Work @default.
- W4324144311 citedByCount "1" @default.
- W4324144311 countsByYear W43241443112023 @default.
- W4324144311 crossrefType "journal-article" @default.
- W4324144311 hasAuthorship W4324144311A5001438849 @default.
- W4324144311 hasAuthorship W4324144311A5010201318 @default.
- W4324144311 hasAuthorship W4324144311A5012169173 @default.
- W4324144311 hasAuthorship W4324144311A5013241767 @default.
- W4324144311 hasAuthorship W4324144311A5025327083 @default.
- W4324144311 hasAuthorship W4324144311A5027733252 @default.
- W4324144311 hasAuthorship W4324144311A5030788778 @default.
- W4324144311 hasAuthorship W4324144311A5037908394 @default.
- W4324144311 hasAuthorship W4324144311A5044247994 @default.
- W4324144311 hasAuthorship W4324144311A5044489687 @default.
- W4324144311 hasAuthorship W4324144311A5054770306 @default.
- W4324144311 hasAuthorship W4324144311A5055575949 @default.
- W4324144311 hasAuthorship W4324144311A5063781871 @default.
- W4324144311 hasAuthorship W4324144311A5068203031 @default.
- W4324144311 hasAuthorship W4324144311A5082326885 @default.
- W4324144311 hasAuthorship W4324144311A5089084282 @default.
- W4324144311 hasBestOaLocation W43241443111 @default.
- W4324144311 hasConcept C121332964 @default.
- W4324144311 hasConcept C121608353 @default.
- W4324144311 hasConcept C126322002 @default.
- W4324144311 hasConcept C141071460 @default.
- W4324144311 hasConcept C142424586 @default.
- W4324144311 hasConcept C143998085 @default.
- W4324144311 hasConcept C2777701055 @default.
- W4324144311 hasConcept C2779338263 @default.
- W4324144311 hasConcept C29730261 @default.
- W4324144311 hasConcept C3875195 @default.
- W4324144311 hasConcept C509974204 @default.
- W4324144311 hasConcept C71924100 @default.
- W4324144311 hasConcept C72563966 @default.
- W4324144311 hasConcept C87355193 @default.
- W4324144311 hasConceptScore W4324144311C121332964 @default.
- W4324144311 hasConceptScore W4324144311C121608353 @default.
- W4324144311 hasConceptScore W4324144311C126322002 @default.
- W4324144311 hasConceptScore W4324144311C141071460 @default.
- W4324144311 hasConceptScore W4324144311C142424586 @default.
- W4324144311 hasConceptScore W4324144311C143998085 @default.
- W4324144311 hasConceptScore W4324144311C2777701055 @default.
- W4324144311 hasConceptScore W4324144311C2779338263 @default.
- W4324144311 hasConceptScore W4324144311C29730261 @default.
- W4324144311 hasConceptScore W4324144311C3875195 @default.
- W4324144311 hasConceptScore W4324144311C509974204 @default.
- W4324144311 hasConceptScore W4324144311C71924100 @default.
- W4324144311 hasConceptScore W4324144311C72563966 @default.